Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test SU011248 (sunitinib) in combination with
paclitaxel/carboplatin. This combination regimen will be tested for safety and antitumor
activity.